Who Supplies Cyclosporine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Cyclosporine exports, with 177+ registered manufacturers shipping to buyers across 100+ countries — yet a handful of companies dominate the shipments. STRIDES PHARMA SCIENCE LIMITED holds the largest share at 21.8% (export value: $2.6M). Close behind, CONCORD BIOTECH LIMITED (19.6%, $2.4M). PANACEA BIOTEC PHARMA LIMITED (12.1%, $1.5M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Cyclosporine? Top Manufacturers & Their Buyers
Flow of Cyclosporine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Cyclosporine Supplier Network — Key Market Intelligence
The Cyclosporine export market from India is led by STRIDES PHARMA SCIENCE LIMITED, which alone commands a 21.8% share, shipping $2.6M worth of product across 62 shipments. The second-largest exporter, CONCORD BIOTECH LIMITED, contributes $2.4M (19.6%) to the overall market. Combined, the top two suppliers alone account for 41.4% of all Cyclosporine exports, indicating a relatively concentrated supply base.
Across all 177 tracked manufacturers, the total Cyclosporine export value stands at $12.1M from 2.5K shipments. The market average shipment value is $4.8K. The single largest buyer relationship in terms of trade value is PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED, receiving $2.4M worth of product.
The combined buyer network spans 12 named purchasing companies, including AVET PHARMACCEUTICALS INC., SENSUM SISTEMI Z RAC, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED, BANCO BOLIVARIANO C., GENERICS & SPECIALIT and 7 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1STRIDES PHARMA SCIENCE LIMITED
STRIDES PHARMA SCIENCE LIMITED is the first-largest Cyclosporine exporter from India, with a market share of 21.8% and a total export value of $2.6M across 62 shipments. Their average shipment value of $42.7K is above the market average of $4.8K, suggesting premium or bulk contract pricing.
STRIDES PHARMA SCIENCE LIMITED serves 4 named buyers in our database. AVET PHARMACCEUTICALS INC. is the dominant customer, accounting for 55.9% of this supplier's tracked business. Top customers include:
• AVET PHARMACCEUTICALS INC. — $1.5M across 35 shipments (55.9% of this supplier's total exports)
• AVET PHARMACCEUTICALS INC. — $820.8K across 19 shipments (31.0% of this supplier's total exports)
• AVET PHARMACCEUTICALS INC. — $348.5K across 8 shipments (13.2% of this supplier's total exports)
• SENSUM SISTEMI Z RAC — $173 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: STRIDES PHARMA SCIENCE LIMITED's per-shipment value of $42.7K is 791% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.
2CONCORD BIOTECH LIMITED
CONCORD BIOTECH LIMITED is the second-largest Cyclosporine exporter from India, with a market share of 19.6% and a total export value of $2.4M across 14 shipments. Their average shipment value of $169.6K is above the market average of $4.8K, suggesting premium or bulk contract pricing.
CONCORD BIOTECH LIMITED serves 1 named buyer in our database. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED — $2.4M across 14 shipments (100.0% of this supplier's total exports)
Key Insight: CONCORD BIOTECH LIMITED's per-shipment value of $169.6K is 3438% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.
3PANACEA BIOTEC PHARMA LIMITED
PANACEA BIOTEC PHARMA LIMITED is the third-largest Cyclosporine exporter from India, with a market share of 12.1% and a total export value of $1.5M across 36 shipments. Their average shipment value of $40.9K is above the market average of $4.8K, suggesting premium or bulk contract pricing.
PANACEA BIOTEC PHARMA LIMITED serves 5 named buyers in our database. BANCO BOLIVARIANO C. is the dominant customer, accounting for 80.7% of this supplier's tracked business. Top customers include:
• BANCO BOLIVARIANO C. — $1.2M across 29 shipments (80.7% of this supplier's total exports)
• GENERICS & SPECIALIT — $148.8K across 4 shipments (10.1% of this supplier's total exports)
• RIGHT & BRIGHT INTER — $60.2K across 1 shipments (4.1% of this supplier's total exports)
• BANCO BOLIVARIANCO C — $42.1K across 1 shipments (2.9% of this supplier's total exports)
• PROSALUD FARMA S.A. — $32.5K across 1 shipments (2.2% of this supplier's total exports)
Key Insight: PANACEA BIOTEC PHARMA LIMITED's per-shipment value of $40.9K is 753% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.
4STARCELL BIOTECH LLP
STARCELL BIOTECH LLP is the fourth-largest Cyclosporine exporter from India, with a market share of 4.8% and a total export value of $579.4K across 21 shipments. Their average shipment value of $27.6K is above the market average of $4.8K, suggesting premium or bulk contract pricing.
STARCELL BIOTECH LLP serves 3 named buyers in our database. M/S ARABIAN OASIS COMPANY is the dominant customer, accounting for 57.9% of this supplier's tracked business. Top customers include:
• M/S ARABIAN OASIS COMPANY — $335.6K across 12 shipments (57.9% of this supplier's total exports)
• ARABIAN OASIS COMPANY — $157.3K across 6 shipments (27.2% of this supplier's total exports)
• M/S ARABIAN OASIS COMPANY — $86.5K across 3 shipments (14.9% of this supplier's total exports)
Key Insight: STARCELL BIOTECH LLP's per-shipment value of $27.6K is 475% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.
5GENETEC LIFESCIENCES
GENETEC LIFESCIENCES is the fifth-largest Cyclosporine exporter from India, with a market share of 3.3% and a total export value of $402.2K across 20 shipments. Their average shipment value of $20.1K is above the market average of $4.8K, suggesting premium or bulk contract pricing.
GENETEC LIFESCIENCES serves 1 named buyer in our database. APRAMEYA PHARMACHEM is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• APRAMEYA PHARMACHEM — $402.2K across 20 shipments (100.0% of this supplier's total exports)
Key Insight: GENETEC LIFESCIENCES's per-shipment value of $20.1K is 319% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.
6MODERN DRUG HOUSE
MODERN DRUG HOUSE is the fifth-largest Cyclosporine exporter from India, with a market share of 2.9% and a total export value of $350.9K across 29 shipments. Their average shipment value of $12.1K is above the market average of $4.8K, suggesting premium or bulk contract pricing.
MODERN DRUG HOUSE serves 2 named buyers in our database. REPUBLIC OF YEMEN CLIENT CODE 02 is the dominant customer, accounting for 80.0% of this supplier's tracked business. Top customers include:
• REPUBLIC OF YEMEN CLIENT CODE 02 — $280.9K across 23 shipments (80.0% of this supplier's total exports)
• REPUBLIC OF YEMEN CLIENT CODE 02 — $70.1K across 6 shipments (20.0% of this supplier's total exports)
Key Insight: MODERN DRUG HOUSE's per-shipment value of $12.1K is 152% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Cyclosporine Flows
Once Cyclosporine leaves the manufacturing plants of companies like STRIDES PHARMA SCIENCE LIMITED and CONCORD BIOTECH LIMITED, it travels to 5 destination markets with a combined import value of $12.1M. United States absorbs the largest share at 26.8% ($3.2M), followed by Turkey (22.6%) and Ecuador (10.4%).
In United States — the top destination — named importers include AVET PHARMACCEUTICALS INC.,, AVET PHARMACCEUTICALS INC, AVET PHARMACCEUTICALS INC.. In Turkey, key buyers are PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED.
This geographic spread reflects Cyclosporine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Cyclosporine Go? Top Importing Countries & Their Buyers
Trade flow of Cyclosporine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Cyclosporine imports from India, with a total trade value of $3.2M across 60 shipments — representing a 26.8% share of all Cyclosporine exports. The average shipment value of $54.1K is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Cyclosporine importers in United States: AVET PHARMACCEUTICALS INC., is the largest buyer, accounting for 54.9% ($1.8M) of this market's total imports.
• AVET PHARMACCEUTICALS INC., — $1.8M (54.9% of United States's total)
• AVET PHARMACCEUTICALS INC — $1.1M (34.3% of United States's total)
• AVET PHARMACCEUTICALS INC. — $348.5K (10.7% of United States's total)
Key Insight: United States's per-shipment average of $54.1K (1028% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Cyclosporine imports from India.
2Turkey
Turkey ranks as the second-largest destination for Cyclosporine imports from India, with a total trade value of $2.7M across 14 shipments — representing a 22.6% share of all Cyclosporine exports. The average shipment value of $196.0K is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Cyclosporine importers in Turkey: PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED is the largest buyer, accounting for 86.6% ($2.4M) of this market's total imports.
• PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED — $2.4M (86.6% of Turkey's total)
Key Insight: Turkey's per-shipment average of $196.0K (3987% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Turkey is a key market for Cyclosporine imports from India.
3Ecuador
Ecuador ranks as the third-largest destination for Cyclosporine imports from India, with a total trade value of $1.3M across 0 shipments — representing a 10.4% share of all Cyclosporine exports. The average shipment value of $1.3M is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations.
Key Insight: Ecuador's per-shipment average of $1.3M (26280% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ecuador is a key market for Cyclosporine imports from India.
4United Arab Emirates
United Arab Emirates ranks as the fourth-largest destination for Cyclosporine imports from India, with a total trade value of $992.0K across 0 shipments — representing a 8.2% share of all Cyclosporine exports. The average shipment value of $992.0K is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Arab Emirates's per-shipment average of $992.0K (20589% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Cyclosporine imports from India.
5Saudi Arabia
Saudi Arabia ranks as the fifth-largest destination for Cyclosporine imports from India, with a total trade value of $581.3K across 18 shipments — representing a 4.8% share of all Cyclosporine exports. The average shipment value of $32.3K is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Cyclosporine importers in Saudi Arabia: M/S ARABIAN OASIS COMPANY is the largest buyer, accounting for 57.7% ($335.6K) of this market's total imports.
• M/S ARABIAN OASIS COMPANY — $335.6K (57.7% of Saudi Arabia's total)
• ARABIAN OASIS COMPANY — $157.3K (27.1% of Saudi Arabia's total)
Key Insight: Saudi Arabia's per-shipment average of $32.3K (574% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Cyclosporine imports from India.
People Also Ask — Cyclosporine Supplier & Trade Network
Who are the top suppliers of Cyclosporine from India?+
Which companies buy Cyclosporine from Indian manufacturers?+
Where does Cyclosporine exported from India go?+
What is the market share of the top Cyclosporine supplier from India?+
What is the average shipment value for Cyclosporine exports from India?+
Is Cyclosporine manufactured in India and exported globally?+
Which country imports the most Cyclosporine from India?+
Who are the buyers of Cyclosporine in Turkey?+
How concentrated is the Cyclosporine supplier market in India?+
How do I find verified buyers for Cyclosporine in specific countries?+
Cyclosporine Trade Network — Key Takeaways
- 1STRIDES PHARMA SCIENCE LIMITED is India's dominant Cyclosporine exporter with a 21.8% market share and $2.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 177 suppliers collectively account for 64.5% of all tracked Cyclosporine exports, with a combined trade value of $12.1M.
- 3United States is the largest destination market, absorbing 26.8% of India's Cyclosporine exports ($3.2M). Turkey (22.6%) and Ecuador (10.4%) follow.
- 4With 2.5K total shipments averaging $4.8K each, the Cyclosporine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AVET PHARMACCEUTICALS INC., AVET PHARMACCEUTICALS INC., PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED, BANCO BOLIVARIANO C. — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 4 customers
6 suppliers → 100 countries
Network value: $12.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclosporine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cyclosporine.
- 2.Flow Mapping: 177 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,531 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 100 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,531 Verified Shipments
177 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists